{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T14:14:15Z","timestamp":1783779255973,"version":"3.55.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"23","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Jiande Science and Technology Development Plan Project","award":["2021YW08"],"award-info":[{"award-number":["2021YW08"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,5]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      The digoxin drug has a narrow therapeutic window that requires regular blood concentration monitoring in a tertiary hospital. The concentration of a drug varies due to several factors. The factors may include physiological and biochemical factors, comorbidities, and concomitant medications. The purpose of this study was to analyze the monitoring data of serum digoxin concentration (SDC) using logistic regression and to find the SDC correlated factors. SDC with a cutoff value of 0.9\u2009ng\/mL, which corresponds to the proposed safety upper limit by international heart failure recommendations (ACCF\/AHA). This cross-sectional study retrospectively analyzed data from 178 patients at Jiande First People\u2019s Hospital, including SDC, demographic characteristics, biochemical parameters, comorbidities, and medication use. Patients were stratified into 2 groups based on an SDC cutoff of 0.9\u2009ng\/mL (&lt;0.9 vs \u22650.9\u2009ng\/mL) to describe population characteristics and perform comparative analyses, including univariate logistic regression. Variables with\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.1 in the univariate analysis were included in a stepwise regression model. Factors with\n                      <jats:italic toggle=\"yes\">P\u2005<\/jats:italic>\n                      &lt;\u2005.05 which remained in the final model. Among 178 patients, those with SDC\u2005&lt;\u20050.9\u2009ng\/mL accounted for 43.26%, while patients with SDC\u2005\u2265\u20050.9\u2009ng\/ml comprised 56.74%. The median SDC was 1.05\u2009ng\/ml (IQR: 0.54, 1.60). Univariate analysis revealed several factors significantly associated with SDC levels. The results of multivariate logistic regression indicated that age (odds ratio [OR]\u2005=\u20051.10, 95% confidence interval [CI]: 1.05\u20131.15,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001), chloride ion (Cl\n                      <jats:sup>-<\/jats:sup>\n                      ) (OR\u2005=\u20050.87, 95% CI: 0.81\u20130.94,\n                      <jats:italic toggle=\"yes\">P\u2005<\/jats:italic>\n                      &lt;\u2005.001), high-density lipoprotein cholesterol (HDLC) (OR\u2005=\u20050.08, 95% CI: 0.02\u20130.30,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001), blood urea nitrogen (BUN) (OR\u2005=\u20051.15, 95% CI: 1.07\u20131.25,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001), Deslanoside (OR\u2005=\u20055.41, 95% CI: 1.39\u201321.15,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.015), and hypoglycemic drugs (OR\u2005=\u20050.30, 95% CI: 0.10\u20130.89,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.030) were all significantly associated with SDC levels. Age, Cl\n                      <jats:sup>-<\/jats:sup>\n                      , HDLC, BUN, Deslanoside, and hypoglycemic drugs are independent factors influencing SDC. These findings provide valuable references for the rational clinical use of digoxin.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049186","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T04:00:22Z","timestamp":1780718422000},"page":"e49186","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["An analysis of digoxin serum concentrations and influencing factors: A cross-sectional study from a tertiary hospital in China"],"prefix":"10.1097","volume":"105","author":[{"given":"Wei","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Pharmacy, the First People\u2019s Hospital of Jiande, Jiande, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, the First People\u2019s Hospital of Jiande, Jiande, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5567-6956","authenticated-orcid":false,"given":"Guilin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, the First People\u2019s Hospital of Jiande, Jiande, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260711","first-page":"1036","article-title":"Evaluation of therapeutic and toxic levels of serum digoxin concentration: a cross-sectional study from a tertiary hospital.","volume":"28","author":"Koca","year":"2024","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R2-20260711","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.amjmed.2020.05.030","article-title":"Digoxin initiation and outcomes in patients with heart failure (HFrEF and HFpEF) and atrial fibrillation.","volume":"133","author":"Singh","year":"2020","journal-title":"Am J Med"},{"key":"R3-20260711","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jacc.2017.12.060","article-title":"Digoxin and mortality in patients with atrial fibrillation.","volume":"71","author":"Lopes","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R4-20260711","first-page":"235","article-title":"Chinese guidelines for the diagnosis and treatment of heart failure 2024.","volume":"52","author":"Zhang","year":"2024","journal-title":"Chinese J Cardiol"},{"key":"R5-20260711","doi-asserted-by":"crossref","first-page":"1179892","DOI":"10.3389\/fcvm.2023.1179892","article-title":"Review: failure of current digoxin monitoring for toxicity: new monitoring recommendations to maintain therapeutic levels for efficacy.","volume":"10","author":"Gona","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"R6-20260711","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1253\/circj.CJ-66-0138","article-title":"Guidelines for therapeutic drug monitoring of cardiovascular drugs clinical use of blood drug concentration monitoring (JCS 2015) - digest version.","volume":"81","author":"Aonuma","year":"2017","journal-title":"Circ J"},{"key":"R7-20260711","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1248\/bpb.b19-01116","article-title":"Frequency of clinical monitoring of serum concentrations of digoxin, potassium, and creatinine, and recording of electrocardiograms in digoxin-treated patients: a japanese claims database analysis.","volume":"43","author":"Ooba","year":"2020","journal-title":"Biol Pharm Bull"},{"key":"R8-20260711","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/clc.23500","article-title":"The impact of serum concentration-guided digoxin therapy on mortality of heart failure patients: a long-term follow-up, propensity-matched cohort study.","volume":"43","author":"Muk","year":"2020","journal-title":"Clin Cardiol"},{"key":"R9-20260711","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jacc.2018.04.044","article-title":"Reference for serum digoxin concentration should be redefined now.","volume":"72","author":"Chen","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R10-20260711","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1001\/jamainternmed.2013.7756","article-title":"Reference laboratory values for digoxin following publication of digitalis investigation group (DIG) trial data.","volume":"173","author":"Hauptman","year":"2013","journal-title":"JAMA Intern Med"},{"key":"R11-20260711","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American college of cardiology foundation\/American heart association task force on practice guidelines.","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R12-20260711","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.jacc.2021.12.011","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: executive summary: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines.","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"R13-20260711","doi-asserted-by":"crossref","first-page":"010901","DOI":"10.11613\/BM.2018.010901","article-title":"Appropriateness of digoxin measurement in hospitalized patients.","volume":"28","author":"Oncu","year":"2018","journal-title":"Biochem Med (Zagreb)"},{"key":"R14-20260711","first-page":"1","article-title":"Mice: multivariate imputation by chained equations in R.","volume":"45","author":"van Buuren","year":"2011","journal-title":"J Statist Soft"},{"key":"R15-20260711","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1248\/bpb.b22-00823","article-title":"Machine learning-based prediction of digoxin toxicity in heart failure: a multicenter retrospective study.","volume":"46","author":"Asai","year":"2023","journal-title":"Biol Pharm Bull"},{"key":"R16-20260711","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1592\/phco.2006.26.1.44","article-title":"Evaluation of a sex-based difference in the pharmacokinetics of digoxin.","volume":"26","author":"Lee","year":"2006","journal-title":"Pharmacotherapy"},{"key":"R17-20260711","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2165\/00002018-200730050-00006","article-title":"Age- and gender-specific incidence of hospitalisation for digoxin intoxication.","volume":"30","author":"Aarnoudse","year":"2007","journal-title":"Drug Saf"},{"key":"R18-20260711","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.amjcard.2012.02.028","article-title":"Therapeutic ranges of serum digoxin concentrations in patients with heart failure.","volume":"109","author":"Goldberger","year":"2012","journal-title":"Am J Cardiol"},{"key":"R19-20260711","first-page":"e45419","article-title":"Potential effects of digoxin on renal functions in patients with congestive heart failure.","volume":"15","author":"Alqahtani","year":"2023","journal-title":"Cureus"},{"key":"R20-20260711","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/s12882-021-02562-0","article-title":"The effect of digoxin on renal function in patients with heart failure.","volume":"22","author":"Shah","year":"2021","journal-title":"BMC Nephrol"},{"key":"R21-20260711","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.3390\/jpm12071188","article-title":"Effect of exercise on inflammation in hemodialysis patients: a systematic review.","volume":"12","author":"Melendez Oliva","year":"2022","journal-title":"J Pers Med"},{"key":"R22-20260711","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.3390\/ijerph20054116","article-title":"Effect of a virtual reality exercise on patients undergoing haemodialysis: a randomised controlled clinical trial research protocol.","volume":"20","author":"Melendez-Oliva","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"R23-20260711","doi-asserted-by":"crossref","first-page":"e01050","DOI":"10.1002\/prp2.1050","article-title":"Comparison of creatinine-based equations for estimating renal function for digoxin dose adjustment in patients with atrial fibrillation and heart failure.","volume":"11","author":"Sakai","year":"2023","journal-title":"Pharmacol Res Perspect"},{"key":"R24-20260711","first-page":"e30","article-title":"Blood urea nitrogen to creatinine ratio in differentiation of upper and lower gastrointestinal bleedings; a diagnostic accuracy study.","volume":"7","author":"Zia Ziabari","year":"2019","journal-title":"Arch Acad Emerg Med"},{"key":"R25-20260711","doi-asserted-by":"crossref","first-page":"1074017","DOI":"10.3389\/fpubh.2022.1074017","article-title":"Association between the risk of heart failure hospitalization and end-stage renal disease with digoxin usage in patients with cardiorenal syndrome: a population-based study.","volume":"10","author":"Chang","year":"2022","journal-title":"Front Public Health"},{"key":"R26-20260711","doi-asserted-by":"crossref","first-page":"9","DOI":"10.11622\/smedj.2020005","article-title":"A myriad of electrocardiographic findings associated with digoxin use.","volume":"61","author":"Djohan","year":"2020","journal-title":"Singapore Med J"},{"key":"R27-20260711","doi-asserted-by":"crossref","first-page":"20749","DOI":"10.1038\/s41598-022-25205-2","article-title":"Relationship among surface electric double layer of cardiomyocyte membrane and toxicology of digoxin and opening of ion channels.","volume":"12","author":"Zhou","year":"2022","journal-title":"Sci Rep"},{"key":"R28-20260711","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1365-2125.2003.01824.x","article-title":"Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin-clarithromycin interaction.","volume":"56","author":"Rengelshausen","year":"2003","journal-title":"Br J Clin Pharmacol"},{"key":"R29-20260711","doi-asserted-by":"crossref","first-page":"148","DOI":"10.12793\/tcp.2023.31.e13","article-title":"Effects of rifampin coadministration on the pharmacokinetics of digoxin: a real-world data approach.","volume":"31","author":"Oh","year":"2023","journal-title":"Transl Clin Pharmacol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000049186","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T14:00:35Z","timestamp":1783778435000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000049186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":29,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049186","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"2025-05-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}